| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |